Regencell Bioscience Lim...

NASDAQ: RGC · Real-Time Price · USD
12.93
0.23 (1.81%)
At close: Aug 15, 2025, 2:55 PM

Regencell Bioscience Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q2 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
n/a n/a n/a n/a n/a n/a -2.34B -2.34B -2.34B -2.34B -2.34B -2.34B -2.34B -2.34B n/a n/a n/a
Cost of Revenue
n/a n/a 769.69K 769.69K 769.69K 769.69K 604.4K 604.4K 604.4K 604.4K 877.7M 877.7M 877.7M 877.7M n/a n/a n/a
Gross Profit
n/a n/a -769.69K -769.69K -769.69K -769.69K -2.34B -2.34B -2.34B -2.34B -3.22B -3.22B -3.22B -3.22B n/a n/a n/a
Operating Income
-4.41M -2.43M -2.85M -2.85M -6.28M -6.28M -7.39M -7.39M -7.62M -7.62M -3.66M -3.66M -3.03K -1.38K -1.13K -882.82 -847.6
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-4.03M -2.18M -2.75M -2.75M -6.06M -6.07M -7.25M -7.25M -7.6M -7.6M -3.66M -3.66M -3.01K -1.35K -1.1K -848.2 -830.29
Net Income
-4.09M -2.24M -2.65M -2.65M -5.87M -5.87M -7.17M -7.17M -7.6M -7.6M -3.66M -3.66M -2.98K -1.35K -1.1K -848.2 -830.29
Selling & General & Admin
3.32M 1.85M 1.85M 1.85M 3.92M 3.92M 4.04M 4.04M 4.5M 4.5M 2.55M 2.55M 2.16K 943.04 689.52 436.00 431.07
Research & Development
1.09M 582.26K 232.23K 232.06K 1.58M 1.58M 2.75M 2.75M 2.51M 2.51M 1.12M 1.12M 869.26 438.32 442.57 446.82 416.52
Other Expenses
-55.87 -55.87 -55.87 0.00 0.00 n/a n/a n/a n/a n/a -285.7M -285.7M -285.7M -285.7M n/a n/a n/a
Operating Expenses
4.41M 2.43M 2.08M 2.08M 5.51M 5.51M 6.79M 6.79M 7.02M 7.02M 3.66M 3.66M 3.01K 1.35K 1.1K 848.20 830.29
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
76.90 125.43 193.53 261.63 262.15 262.66 188.99 115.32 70.30 25.28 17.45 9.62 5.60 1.58 57.89 114.21 114.21
Cost & Expenses
4.41M 2.43M 2.85M 2.85M 6.28M 6.28M 7.39M 7.39M 7.62M 7.62M 3.66M 3.66M 3.01K 1.35K 1.1K 848.20 830.29
Income Tax Expense
-119.27K -119.33K -119.33K -119.38K -111.3 -95.6 -136.22 -125.18 -131.79 -121.54 -70.9M -70.9M -70.9M -70.9M n/a n/a n/a
Shares Outstanding (Basic)
13.01M 494.49M 494.49M 494.49M 494.49M 494.49M 494.46M 494.49M 494.46M 494.49M 494.8M 492.75M 478.38M 380M 380M 380M 380M
Shares Outstanding (Diluted)
13.01M 494.49M 494.47M 494.46M 494.46M 494.49M 494.46M 494.49M 494.46M 494.49M 494.8M 492.75M 478.38M 380M 380M 380M 380M
EPS (Basic)
-0.14 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00
EPS (Diluted)
-0.14 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00
EBITDA
-6.22M -5.45M -5.25M -6.63M -7.87M -8.47M -9.82M -10.41M -10.64M -10.79M -7.95M -6.48M -3M -1.35M -1.11M -866.85K -838.14K
EBIT
-5.19M -4.49M -5.06M -6.48M -8.64M -9.2M -10.39M -10.95M -11.29M -11.4M -7.97M -6.5M -3.03M -1.38M -1.13M -882.82K -847.6K
Depreciation & Amortization
247.69K 247.76K 769.91K 769.87K 769.84K 769.8K 604.51K 604.48K 604.45K 604.42K 26.40 26.35 26.40 26.46 22.28 272.89 415.23